blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2385035

EP2385035 - PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR [Right-click to bookmark this link]
Former [2011/45]PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS THEIR PHARMACEUTICAL COMPOSITIONS CONTAING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR
[2014/26]
StatusNo opposition filed within time limit
Status updated on  01.05.2015
Database last updated on 25.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Harbin Gloria Pharmaceuticals Co., Ltd.
No. 29, Beijing Road Limin Economic & Technological Development Zone
Harbin, Heilongjiang 150025 / CN
[2011/45]
Inventor(s)01 / YANG, Xuqing
Room 416 No.2 Building
18 Anning Village East Road
Haidian District
Beijing 100085 / CN
02 / XUE, Long
Room 416 No.2 Building
18 Anning Village East Road
Haidian District
Beijing 100085 / CN
03 / LUO, Juan
Room 416 No.2 Building
18 Anning Village East Road
Haidian District
Beijing 100085 / CN
 [2011/45]
Representative(s)Bösl, Raphael Konrad, et al
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2011/45]Bösl, Raphael Konrad, et al
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Application number, filing date09834119.124.12.2009
WO2009CN76006
Priority number, dateCN20081017659125.12.2008         Original published format: CN200810176591
[2011/45]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010072166
Date:01.07.2010
Language:ZH
[2010/26]
Type: A1 Application with search report 
No.:EP2385035
Date:09.11.2011
Language:EN
[2011/45]
Type: B1 Patent specification 
No.:EP2385035
Date:25.06.2014
Language:EN
[2014/26]
Search report(s)International search report - published on:CN01.07.2010
(Supplementary) European search report - dispatched on:EP11.06.2013
ClassificationIPC:C07D401/14, C07D403/14, A61K31/16, A61P17/06, A61P27/00, A61P29/00, A61P35/00, A61P35/02, A61P9/00, A61P9/10
[2013/28]
CPC:
C07D403/14 (EP,US); C07C233/64 (KR); A61P1/00 (EP);
A61P1/16 (EP); A61P11/02 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D239/42 (EP,US);
C07D401/04 (EP,US); C07D401/14 (EP,US) (-)
Former IPC [2011/45]C07C233/64, A61K31/16, A61P17/06, A61P27/00, A61P29/00, A61P35/00, A61P35/02, A61P9/00, A61P9/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2014/26]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON DIHYDROINDENAMIDVERBINDUNGEN, DEREN PHARMAZEUTISCHE ZUSAMMENSETZUNGEN, DIE VERBINDUNGEN DAVON ENTHALTEN, UND DEREN VERWENDUNG ALS PROTEINKINASEINHIBITOREN[2011/45]
English:PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR[2014/34]
French:PROCÉDÉ DE PRÉPARATION DE COMPOSÉS D'AMIDE DE DIHYDROINDÈNE, COMPOSITIONS PHARMACEUTIQUES CONTENANT LES COMPOSÉS, ET LEUR UTILISATION COMME INHIBITEUR DE PROTÉINES KINASES[2011/45]
Former [2011/45]PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS THEIR PHARMACEUTICAL COMPOSITIONS CONTAING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR
Entry into regional phase08.07.2011Translation filed 
08.07.2011National basic fee paid 
08.07.2011Search fee paid 
08.07.2011Designation fee(s) paid 
08.07.2011Examination fee paid 
Examination procedure08.07.2011Amendment by applicant (claims and/or description)
08.07.2011Examination requested  [2011/45]
21.10.2013Communication of intention to grant the patent
06.02.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
06.02.2014Fee for grant paid
06.02.2014Fee for publishing/printing paid
21.03.2014Communication of intention to grant the patent
06.05.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.10.2013
Opposition(s)26.03.2015No opposition filed within time limit [2015/23]
Fees paidRenewal fee
19.12.2011Renewal fee patent year 03
20.12.2012Renewal fee patent year 04
18.12.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE25.06.2014
BG25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
MC25.06.2014
MK25.06.2014
MT25.06.2014
SI25.06.2014
SK25.06.2014
SM25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
[2018/30]
Former [2016/33]BE25.06.2014
BG25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
MC25.06.2014
MT25.06.2014
SI25.06.2014
SK25.06.2014
SM25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2016/28]BE25.06.2014
BG25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
MC25.06.2014
SI25.06.2014
SK25.06.2014
SM25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2016/27]BE25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
MC25.06.2014
SI25.06.2014
SK25.06.2014
SM25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2016/22]BE25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SI25.06.2014
SK25.06.2014
SM25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2015/50]BE25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SI25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2015/46]BE25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
IE24.12.2014
Former [2015/30]BE25.06.2014
CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
Former [2015/22]CY25.06.2014
DK25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
Former [2015/12]CY25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
IS25.10.2014
PT27.10.2014
Former [2015/11]CY25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
PT27.10.2014
Former [2015/10]CY25.06.2014
EE25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
SK25.06.2014
NO25.09.2014
GR26.09.2014
Former [2014/50]CY25.06.2014
HR25.06.2014
LT25.06.2014
LV25.06.2014
NO25.09.2014
GR26.09.2014
Former [2014/49]CY25.06.2014
LT25.06.2014
NO25.09.2014
Former [2014/48]CY25.06.2014
LT25.06.2014
Former [2014/47]CY25.06.2014
Documents cited:Search[A]WO2004005281  (NOVARTIS AG [CH], et al) [A] 1-15* example 50; claim - *
International search[X]WO2005113494  (AMGEN INC [US], et al);
 [A]WO2005113494  (AMGEN INC [US], et al);
 [A]CN1944398  (INST OF MEDICINES CHINESE ACAD [CN])
by applicant   - COHEN, NAT REV. DRUG DISCOVERY, (2002), vol. 1, page 309
    - DRUKER ET AL., N. ENGL. J, MED., (2006), vol. 355, page 2408
    - NARDI ET AL., CURR. OPIN. HEMATOL., (2004), vol. 11, page 35
    - JOENSUU ET AL., N. ENGF. J. MED., (2001), vol. 344, page 1052
    - EDLING ET AL., INT. J. BIOCHEM. CELL BIOL., (2007), vol. 39, page 1995
    - LENNARTSSON ET AL., CURR. CANCER DRUG TARGETS, (2006), vol. 6, page 65
    - REBER ET AL., EUR. J. PHARMACOL, (2006), vol. 533, page 327
    - PANIAGUA ET AL., NAT. CLIN. PROC. RHEUM., (2007), vol. 3, page 190
    - ANDRAE ET AL., GENE DEV., (2008), vol. 22, page 1276
    - PANIAGUA ET AL., NAT. CLIN. PRAC. RHEUM., (2007), vol. 3, page 190
    - LOUVET ET AL., PROC. NATL. ACOD. SCI. USA, (2008), vol. 105, page 18895
    - Remington's Pharmaceutical Sciences, MARK PUBLISHING COMPANY, (1985), page 1418
    - JOURNAL OF PHARMACEUTICAL SCIENCE, (1977), vol. 66, page 2
    - T. HIGUCHI, V. STELLA, Pro-drugs as Novel Delivery Systems, A.C.S. SYMPOSIUM SERIES, vol. 14
    - SZAKACS ET AL., J. MED, CHEM, (2005), vol. 48, page 249
    - Z. SZAKACS ET AL., J. MED. CHEM., (2005), vol. 48, page 249
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.